{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:49:58Z","timestamp":1761752998552,"version":"build-2065373602"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Changzheng Hospital Grant","award":["2023YJBF-PY12","2023YJBF-PY12"],"award-info":[{"award-number":["2023YJBF-PY12","2023YJBF-PY12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21754-4","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:45:56Z","timestamp":1761752756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenic genes associated with immune-related genes in graves\u2019 disease: a multi-omics Mendelian randomization analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Qianfei","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"21754_CR1","doi-asserted-by":"publisher","first-page":"101387","DOI":"10.1016\/j.beem.2020.101387","volume":"34","author":"A Antonelli","year":"2020","unstructured":"Antonelli, A. et al. Graves\u2019 disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract. Res. Clin. Endocrinol. Metab. 34, 101387 (2020).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"21754_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.beem.2018.03.014","volume":"32","author":"J L\u00e9ger","year":"2018","unstructured":"L\u00e9ger, J. & Carel, J. C. Diagnosis and management of hyperthyroidism from prenatal life to adolescence. Best Pract. Res. Clin. Endocrinol. Metab. 32, 373\u2013386 (2018).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"21754_CR3","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","volume":"105","author":"GJ Kahaly","year":"2020","unstructured":"Kahaly, G. J. Management of graves thyroidal and extrathyroidal disease: an update. J. Clin. Endocrinol. Metab. 105, 3704\u20133720 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"21754_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. Nat. Immunol. 19, 665\u2013673 (2018).","journal-title":"Nat. Immunol."},{"key":"21754_CR5","doi-asserted-by":"publisher","first-page":"879824","DOI":"10.3389\/fimmu.2022.879824","volume":"13","author":"H Zheng","year":"2022","unstructured":"Zheng, H. et al. A global regulatory network for dysregulated gene expression and abnormal metabolic signaling in immune cells in the microenvironment of graves\u2019 disease and hashimoto\u2019s thyroiditis. Front. Immunol. 13, 879824 (2022).","journal-title":"Front. Immunol."},{"key":"21754_CR6","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.4049\/jimmunol.181.8.5768","volume":"181","author":"RS Douglas","year":"2008","unstructured":"Douglas, R. S. et al. B cells from patients with graves\u2019 disease aberrantly express the IGF-1 receptor: Implications for disease pathogenesis. J. Immunol. 181, 5768\u20135774 (2008).","journal-title":"J. Immunol."},{"key":"21754_CR7","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","volume":"170","author":"J Pritchard","year":"2003","unstructured":"Pritchard, J., Han, R., Horst, N., Cruikshank, W. W. & Smith, T. J. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with graves\u2019 disease is mediated through the insulin-like growth factor I receptor pathway. J. Immunol. 170, 6348\u20136354 (2003).","journal-title":"J. Immunol."},{"key":"21754_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","volume":"30","author":"EM Jacobson","year":"2008","unstructured":"Jacobson, E. M., Huber, A. & Tomer, Y. The HLA gene complex in thyroid autoimmunity: From epidemiology to etiology. J. Autoimmun. 30, 58\u201362 (2008).","journal-title":"J. Autoimmun."},{"key":"21754_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1365-2265.2003.01778.x","volume":"58","author":"B Vaidya","year":"2003","unstructured":"Vaidya, B. et al. CTLA4 gene and graves\u2019 disease: Association of graves\u2019 disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin. Endocrinol. (Oxf). 58, 732\u2013735 (2003).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"21754_CR10","volume-title":"Graves\u2019 Disease","author":"SK Mosin","year":"2021","unstructured":"Mosin, S. K., Suhail, S. L., Sunia, F., Iqra, F. & Sabhiya, M. Graves\u2019 disease: Pathophysiology, genetics and management. In Robert, G. (ed.) Graves\u2019 Disease. Rijeka: IntechOpen; p. (2021). Ch. 4."},{"key":"21754_CR11","doi-asserted-by":"crossref","unstructured":"Lanzolla, G., Marin\u00f2, M. & Menconi, F. Graves disease: Latest understanding of pathogenesis and treatment options. Nature Reviews Endocrinology (2024).","DOI":"10.1038\/s41574-024-01016-5"},{"key":"21754_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506\u2013511 (2003).","journal-title":"Nature"},{"key":"21754_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/BF03346682","volume":"33","author":"W Zhu","year":"2010","unstructured":"Zhu, W. et al. Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with graves\u2019 disease. J. Endocrinol. Invest. 33, 751\u2013755 (2010).","journal-title":"J. Endocrinol. Invest."},{"key":"21754_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13044-018-0046-9","volume":"11","author":"M Rydzewska","year":"2018","unstructured":"Rydzewska, M., Jaromin, M., Pasierowska, I. E., Sto\u017cek, K. & Bossowski, A. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res. 11, 2 (2018).","journal-title":"Thyroid Res."},{"key":"21754_CR15","doi-asserted-by":"publisher","first-page":"618829","DOI":"10.3389\/fgene.2021.618829","volume":"12","author":"L Lin","year":"2021","unstructured":"Lin, L. et al. Mendelian randomization with refined instrumental variables from genetic score improves accuracy and reduces bias. Front. Genet. 12, 618829 (2021).","journal-title":"Front. Genet."},{"key":"21754_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat. Commun. 9, 918 (2018).","journal-title":"Nat. Commun."},{"key":"21754_CR17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin, C. A., Khera, A. V. & Kathiresan, S. Mendelian Randomization JAMA 318, 1925\u20131926 (2017).","journal-title":"Mendelian Randomization JAMA"},{"key":"21754_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"21754_CR19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"key":"21754_CR20","doi-asserted-by":"publisher","first-page":"eabj1541","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).","journal-title":"Science"},{"key":"21754_CR21","doi-asserted-by":"crossref","unstructured":"Jin, C., Lee, B., Shen, L. & Long, Q. Integrating multi-omics summary data using a Mendelian randomization framework. Brief Bioinform 23, (2022).","DOI":"10.1093\/bib\/bbac376"},{"key":"21754_CR22","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41467-018-04558-1","volume":"9","author":"T Qi","year":"2018","unstructured":"Qi, T. et al. Identifying gene targets for brain-related traits using transcriptomic and Methylomic data from blood. Nat. Commun. 9, 2282 (2018).","journal-title":"Nat. Commun."},{"key":"21754_CR23","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1038\/s41467-024-46063-8","volume":"15","author":"J Advani","year":"2024","unstructured":"Advani, J. et al. QTL mapping of human retina DNA methylation identifies 87 gene-epigenome interactions in age-related macular degeneration. Nat. Commun. 15, 1972 (2024).","journal-title":"Nat. Commun."},{"key":"21754_CR24","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).","journal-title":"PLoS Genet."},{"key":"21754_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13073-023-01255-7","volume":"16","author":"S Ghatan","year":"2024","unstructured":"Ghatan, S. et al. Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations. Genome Med. 16, 10 (2024).","journal-title":"Genome Med."},{"key":"21754_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41586-023-06034-3","volume":"617","author":"E Pairo-Castineira","year":"2023","unstructured":"Pairo-Castineira, E. et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature 617, 764\u2013768 (2023).","journal-title":"Nature"},{"key":"21754_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481\u2013487 (2016).","journal-title":"Nat. Genet."},{"key":"21754_CR28","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s10096-020-03890-z","volume":"39","author":"G Li","year":"2020","unstructured":"Li, G. et al. Identification of hypervirulent Klebsiella pneumoniae isolates using the string test in combination with galleria Mellonella infectivity. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1673\u20131679 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"21754_CR29","doi-asserted-by":"crossref","unstructured":"Shih, S-R. et al., Fibroblast growth factor receptor inhibitors reduce adipogenesis of orbital fibroblasts and enhance myofibroblastic differentiation in Graves\u2019 orbitopathy. 29, 193\u2013202 (2021).","DOI":"10.1080\/09273948.2019.1672196"},{"key":"21754_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","volume":"22","author":"R Ruan","year":"2023","unstructured":"Ruan, R. et al. Unleashing the potential of combining FGFR inhibitor and immune checkpoint Blockade for FGF\/FGFR signaling in tumor microenvironment. Mol. Cancer. 22, 60 (2023).","journal-title":"Mol. Cancer"},{"key":"21754_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41586-022-05173-3","volume":"609","author":"J Duan","year":"2022","unstructured":"Duan, J. et al. Hormone- and antibody-mediated activation of the Thyrotropin receptor. Nature 609, 854\u2013859 (2022).","journal-title":"Nature"},{"key":"21754_CR32","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/hmg\/ddp087","volume":"18","author":"OJ Brand","year":"2009","unstructured":"Brand, O. J. et al. Association of the thyroid stimulating hormone receptor gene (TSHR) with graves\u2019 disease. Hum. Mol. Genet. 18, 1704\u20131713 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"21754_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/labmed\/lmac008","volume":"53","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Jin, B., Huang, Y. & Dong, A. Consistency between Thyrotropin receptor antibody (TRAb) and Thyroid-Stimulating antibody (TSAb) levels in patients with graves disease. Lab. Med. 53, 412\u2013416 (2022).","journal-title":"Lab. Med."},{"key":"21754_CR34","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1007\/978-3-319-67199-4_102000","volume-title":"Encyclopedia of Signaling Molecules","author":"N Swain","year":"2018","unstructured":"Swain, N., Pathak, J., Patel, S. & Hosalkar, R. M. MMP-9. In Choi, S. (ed) Encyclopedia of signaling molecules 3162\u20133167 (Springer, 2018)."},{"key":"21754_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.17219\/acem\/68991","volume":"27","author":"K Kapelko-S\u0142owik","year":"2018","unstructured":"Kapelko-S\u0142owik, K. et al. Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with graves\u2019 orbitopathy. Adv. Clin. Exp. Med. 27, 99\u2013103 (2018).","journal-title":"Adv. Clin. Exp. Med."},{"key":"21754_CR36","doi-asserted-by":"crossref","unstructured":"Fingleton, B. Matrix metalloproteinases as regulators of inflammatory processes. Biochim. et Biophys. Acta (BBA) Mol. Cell Res. 1864, 2036\u20132042 (2017).","DOI":"10.1016\/j.bbamcr.2017.05.010"},{"key":"21754_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mce.2016.04.008","volume":"430","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Enhancement of CD4(+) T cell response and survival via coexpressed OX40\/OX40L in graves\u2019 disease. Mol. Cell. Endocrinol. 430, 115\u2013124 (2016).","journal-title":"Mol. Cell. Endocrinol."},{"key":"21754_CR38","unstructured":"Kulski, J. K. & Inoko, H. J. L. Major histocompatibility complex (MHC) genes. (2001)."},{"key":"21754_CR39","first-page":"1569","volume":"76","author":"T Yanagawa","year":"1993","unstructured":"Yanagawa, T. et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to graves\u2019 disease in a Caucasian population. J. Clin. Endocrinol. Metab. 76, 1569\u20131574 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"21754_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/138920207783591690","volume":"8","author":"SC Gough","year":"2007","unstructured":"Gough, S. C. & Simmonds, M. J. The HLA region and autoimmune disease: Associations and mechanisms of action. Curr. Genomics. 8, 453\u2013465 (2007).","journal-title":"Curr. Genomics"},{"key":"21754_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-021-02743-9","volume":"74","author":"M Fichna","year":"2021","unstructured":"Fichna, M. et al. Polymorphism in BACH2 gene is a marker of polyglandular autoimmunity. Endocrine 74, 72\u201379 (2021).","journal-title":"Endocrine"},{"key":"21754_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3389\/fendo.2019.00613","volume":"10","author":"Q Yao","year":"2019","unstructured":"Yao, Q. et al. Increased human Interleukin-32 expression is related to disease activity of graves\u2019 disease. Front. Endocrinol. (Lausanne). 10, 613 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"21754_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: Current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).","journal-title":"Blood Cancer J."},{"key":"21754_CR44","doi-asserted-by":"publisher","first-page":"112470","DOI":"10.1016\/j.biopha.2021.112470","volume":"147","author":"N Li","year":"2022","unstructured":"Li, N. et al. Biomarkers related to immune checkpoint inhibitors therapy. Biomed. Pharmacother. 147, 112470 (2022).","journal-title":"Biomed. Pharmacother"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21754-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:45:58Z","timestamp":1761752758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21754-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21754"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21754-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37875"}}